Nelfinavir

Known as: NFV, Nelfinavir [Chemical/Ingredient] 
A synthetic antiviral agent that selectively binds to and inhibits human immunodeficiency virus (HIV) protease. Nelfinavir has activity against HIV 1… (More)

Topic mentions per year

Topic mentions per year

1984-2018
05010019842018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
In an operator's datacenter, optical technologies can be employed to perform network function (NF) chaining for larger aggregated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Mobile carrier networks follow an architecture where network elements and their interfaces are defined in detail through… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND. The risk of myocardial infarction (MI) in patients with human immunodeficiency virus (HIV) infection has been… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE The development of new cancer drugs is slow and costly. HIV protease inhibitors are Food and Drug Administration approved… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND Efavirenz and nelfinavir are metabolized by cytochrome P-450 (CYP) 2B6 and CYP2C19, respectively, with some… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
BACKGROUND Lopinavir is a newly developed inhibitor of human immunodeficiency virus (HIV) protease that, when formulated with… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
CONTEXT Use of antiretroviral drugs, including protease inhibitors, for treatment of human immunodeficiency virus (HIV) infection… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
1999
1999
BACKGROUND Consistent long-term viral suppression has been difficult to achieve in children with human immunodeficiency virus… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND In clinical trials, highly active antiretroviral therapy (HAART) reduces plasma HIV-1 RNA levels to less than 500… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Currently available HIV-1 protease inhibitors are potent agents in the therapy of HIV-1 infection. However, limited oral… (More)
  • figure 2
  • figure 3
  • table I
  • figure 4
  • table II
Is this relevant?